Education
About Us
Working with TipRanks
Follow Us
Novonesis (NVZMY)
OTHER OTC:NVZMY
NVZMY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$54.26 - $75.69
Previous CloseN/A
Volume8.66K
Average Volume (3M)161.00
Market Cap
$34.99B
Enterprise Value$96.32B
Total Cash (Recent Filing)$256.50M
Total Debt (Recent Filing)kr1.70B
Price to Earnings (P/E)104.7
Beta0.38
Next Earnings
Aug 21, 2025EPS Estimate
0.75Last Dividend Ex-Date
Apr 07, 2025Dividend Yield1.65%
Share Statistics
EPS (TTM)0.47
Shares Outstanding414,555,050
10 Day Avg. Volume0
30 Day Avg. Volume161
Financial Highlights & Ratios
PEG Ratio-65.33
Price to Book (P/B)8.09
Price to Sales (P/S)0.00
P/FCF Ratio42.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Novonesis News
PremiumCompany Announcements
Novozymes A/S: Strong Start to 2025 Earnings Call
PremiumCompany Announcements
Novozymes A/S Reports Strong Q1 2025 Performance
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
NVZMY FAQ
What was Novonesis’s price range in the past 12 months?
Novonesis lowest stock price was $54.26 and its highest was $75.69 in the past 12 months.
What is Novonesis’s market cap?
Novonesis’s market cap is $34.99B.
When is Novonesis’s upcoming earnings report date?
Novonesis’s upcoming earnings report date is Aug 21, 2025 which is in 63 days.
How were Novonesis’s earnings last quarter?
Novonesis released its earnings results on May 08, 2025. The company reported $0.474 earnings per share for the quarter, beating the consensus estimate of $0.437 by $0.037.
Is Novonesis overvalued?
According to Wall Street analysts Novonesis’s price is currently Overvalued.
Does Novonesis pay dividends?
Novonesis pays a Semiannually dividend of $0.614 which represents an annual dividend yield of 1.65%. See more information on Novonesis dividends here
What is Novonesis’s EPS estimate?
Novonesis’s EPS estimate is 0.75.
How many shares outstanding does Novonesis have?
Novonesis has 414,555,050 shares outstanding.
What happened to Novonesis’s price movement after its last earnings report?
Novonesis reported an EPS of $0.474 in its last earnings report, beating expectations of $0.437. Following the earnings report the stock price went up 3.546%.
Which hedge fund is a major shareholder of Novonesis?
Currently, no hedge funds are holding shares in NVZMY
Novonesis Stock Smart Score
Company Description
Novonesis
Novonesis (NVZMY) is an innovative technology company specializing in the development and deployment of advanced data analytics and artificial intelligence solutions. The company operates primarily in the technology sector, offering a suite of products that enhance data-driven decision-making processes for businesses across various industries. Novonesis aims to empower organizations by providing them with the tools to harness the power of their data effectively.
NVZMY Company Deck
NVZMY Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong start to 2025 with robust organic sales growth and profitability improvements, despite challenges from market exits and currency headwinds. The company's diversified portfolio and strategic acquisitions position it well for future growth.Read More>NVZMY Revenue Breakdown
28.53% Household Care
24.83% Bioenergy
22.07% Food, Beverages & Human Health
12.82% Grain & Tech Processing
11.75% Agriculture & Animal Health
Technical Analysis
Eastman Chemical
―
LyondellBasell
―
PPG Industries
―
RPM International
―
DuPont de Nemours
―